Brian is a supporter of the Affordable Care Act recognizing the law was a beginning, not an end to expanding, improving, and providing more affordable healthcare options for Americans. He supports legislation aimed at bringing down the cost of prescription drug prices and is a lead sponsor of a bill that would allow people ages 50-64 to buy into Medicare early.
As Co-Chair of the House of Representatives Cancer Caucus, Brian works with his colleagues to support substantial federal investments in medical research, funding benefiting Roswell Park Comprehensive Cancer Center and the Buffalo Niagara Medical Campus here in Western New York and supporting families fighting horrible diseases and conditions across the nation. He is also a lead sponsor of the Cancer Drug Coverage Parity Act, which requires health insurance companies to provide the same coverage for new, promising orally-administered anti-cancer medication as it does for traditional intravenous chemotherapy.
Brian remains at the forefront of today’s top health discussions ranging from improving mental health services to seeking solutions to combat the opioid epidemic, as a member of the House Ways and Means Subcommittee on Health.
For information about accessing health coverage through the Affordable Care Act visit: https://www.healthcare.gov/
For additional details about health care in New York State go to: https://nystateofhealth.ny.gov/
More on Health Care
Congressman Brian Higgins (NY-26) recently took to the House of Representatives Floor to raise awareness of the need for a renewed national focus on preventing, treating and caring for those with Alzheimer’s disease.
Today, thousands of advocates from across the country gather in Washington, D.C. to rally in support of medical research funding. The crowd in the nation’s capital will include more than 50 researchers from Roswell Park Cancer Institute.
Congressman Brian Higgins (NY-26) announced that researchers at University at Buffalo have been awarded a grant for $333,805 by the National Institute on Drug Abuse to study treatments for chronic pain that will prevent the risk of abuse or development of tolerance.
Congressman Brian Higgins (NY-26) joined Roswell Park Cancer Institute (RPCI) President & CEO Dr. Donald Trump and American Cancer Society Cancer Action Network (ACS CAN) Federal Government Relations Director Hillary Clarke to outline the local impact of federal investments in cancer research and the devastating impact cuts, including possible sequestration, would have on both the economy and the effort to improve cancer outcomes.
Congressman Brian Higgins (NY-26) applauded the work of local families fighting to address the prescription drug epidemic. Late last week three Western New Yorkers testified at a hearing of the U.S. Food and Drug Administration’s (FDA) Drug Safety and Risk Management Advisory Committee. After hearing their stories and other compelling evidence, the panel voted 19-10 to call for stricter controls on the prescription of highly addictive hydrocodone medications.
In advance of hearings on strengthening hydrocodone regulation, Congressman Brian Higgins wrote a letter to the Food and Drug Administration (FDA) asking that the personal experiences of those testifying, including that of Western New Yorker, Avi Israel, be taken into serious consideration as policy considerations are made.